ADM Tronics to Host Shareholder Video Call on March 27 to Update Launch and Significance of Vet-Sonotron Veterinary Pain Treatment Device
- None.
- None.
NORTHVALE, NJ / ACCESSWIRE / March 20, 2024 / ADM Tronics (OTCQB:ADMT), an innovator of electronic medical device technologies, invites shareholders to a shareholder video call on March 27, 2024 at 2 PM Eastern, where shareholders will be updated about ADMT's new proprietary Vet-Sonotron®, non-invasive veterinary therapeutic technology. The Vet-Sonotron has demonstrated positive efficacy in treating pain and inflammation, without drugs nor adverse side effects, and is now in initial commercialization for pets and other animals, including horses.
Based on the positive therapeutic results demonstrated by the Vet-Sonotron, ADMT is in development of a human medical version - the Sonotron. When development is completed, ADMT intends to submit a 510(k) to the FDA for the Sonotron for use in the treatment of chronic and acute musculoskeletal pain conditions in humans. The non-invasive therapy delivered by the Sonotron has no known side effects and may be an effective option to pain drugs that have potential negative side effects and dependencies. Management believes the Sonotron technology has the potential to impact shareholder valuations significantly should FDA clearance be secured.
The shareholder video call will be held March 27, 2024 at 2:00 PM Eastern Daylight Time.
Register in advance for this meeting:
https://us06web.zoom.us/meeting/register/tZcsd-qgqjguG93zMFc_rH4IEpdDYQ2NWjEl
After registering, you will receive a confirmation email containing information about joining the meeting.
For more information about the Vet-Sonotron visit www.vet-sonotron.com.
ADMT welcomes inquiries for its medical device contract engineering and manufacturing services at www.admteng.com.
About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. ADMT has three areas of activity: Proprietary Electronic Medical Devices; Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Water-Based Formulations. The Company's headquarters, laboratories, and FDA-Registered medical device manufacturing operations are in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, for research, development and commercialization of diversified technologies. Visit www.admtronics.com.
Sonotron® is a registered trademark of ADM Tronics Unlimited, Inc.
Investor Relations:
Howard Isaacs 562-987-4939 HISAACS@EARTHLINK.NET
Richard Cavalli 303-956-1777 RICHARDACAVALLI@GMAIL.COM
Except for historical information contained herein, the matters set forth in this news release are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
SOURCE: ADM Tronics Unlimited, Inc.
View the original press release on accesswire.com
FAQ
When is ADMT Tronics holding a shareholder video call?
What is the purpose of the shareholder video call by ADMT Tronics?
What is the ticker symbol for ADMT Tronics?
